BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31124943)

  • 21. The roles of excision repair cross-complementation group1 in objective response after cisplatin-based concurrent chemoradiotherapy and survival in head and neck cancers: a systematic review and meta-analysis.
    Gao Y; Liu D
    Oral Oncol; 2015 Jun; 51(6):570-7. PubMed ID: 25857670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis.
    Liao D; Huang H; Zhu Z; Li T; Li H; Huang GL; He Z
    Minerva Med; 2016 Feb; 107(1):54-61. PubMed ID: 26799856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CUL4A expression is associated with tumor stage and prognosis in nasopharyngeal carcinoma.
    Jin X; Ma YC; Zhu WY; Fan L
    Medicine (Baltimore); 2019 Dec; 98(51):e18036. PubMed ID: 31860954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of tumor-associated macrophages in patients with nasopharyngeal carcinoma: A meta-analysis.
    Chen YL
    Medicine (Baltimore); 2020 Sep; 99(39):e21999. PubMed ID: 32991403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
    Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
    Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with nasopharyngeal cancer.
    Lee HW; Hwang YH; Han JH; Choi JH; Kang SY; Jeong SH; Ann MS; Oh YT; Kim JH; Kim CH; Sheen SS
    Oral Oncol; 2010 Mar; 46(3):209-13. PubMed ID: 20153243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma.
    Jiang W; Liu N; Chen XZ; Sun Y; Li B; Ren XY; Qin WF; Jiang N; Xu YF; Li YQ; Ren J; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Mai HQ; Zeng MS; Kang TB; Jia WH; Shao JY; Ma J
    Mol Cancer Ther; 2015 Dec; 14(12):2864-73. PubMed ID: 26443805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of Serum Lactate Dehydrogenase in Patients with Nasopharyngeal Carcinoma: a Meta-Analysis.
    Zhai C; Gu K; Zhai X; Wang J; Zhang J
    Clin Lab; 2017 Nov; 63(11):1777-1785. PubMed ID: 29226643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormally Expressed Long Non-Coding RNAs in Nasopharyngeal Carcinoma: a Meta-Analysis.
    Xia L; Zhang W; Zhu L; Yu G
    Clin Lab; 2018 Apr; 64(4):585-595. PubMed ID: 29739093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
    Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
    J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma.
    Zhang W; Huang C; Gong Z; Zhao Y; Tang K; Li X; Fan S; Shi L; Li X; Zhang P; Zhou Y; Huang D; Liang F; Zhang X; Wu M; Cao L; Wang J; Li Y; Xiong W; Zeng Z; Li G
    J Mol Histol; 2013 Oct; 44(5):545-54. PubMed ID: 23529758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
    Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
    Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low expression of excision repair cross-complementation group-1 protein predicts better outcome in patients with locally advanced nasopharyngeal cancer treated with concurrent chemoradiotherapy.
    Zhang Z; Jiang C; Hu L
    Tumori; 2014; 100(3):328-32. PubMed ID: 25076246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NEAT1 is a potential prognostic biomarker for patients with nasopharyngeal carcinoma.
    Liu Z; Wu K; Wu J; Tian D; Chen Y; Yang Z; Wu A
    J Cell Biochem; 2019 Jun; 120(6):9831-9838. PubMed ID: 30618186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Outcome-Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma.
    Dai W; Chung DL; Chow LK; Yu VZ; Lei LC; Leong MM; Chan CK; Ko JM; Lung ML
    Clin Cancer Res; 2020 Dec; 26(24):6494-6504. PubMed ID: 32988965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z; Zhao Y
    BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ERCC1 expression levels predict the outcome of platinum-based chemotherapies in advanced bladder cancer: a meta-analysis.
    Li S; Wu J; Chen Y; Tang W; Peng Q; Deng Y; Xie L; Wang J; Huang S; Li R; Qin X; Zhao J
    Anticancer Drugs; 2014 Jan; 25(1):106-14. PubMed ID: 24025563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and predictive role of excision repair cross complementation group 1, ribonucleotide reductase subunit M1, and β-tubulin 3 in postoperative patients with non-small cell lung cancer receiving adjuvant chemotherapy].
    Shi Y; Chen L; Li J; Lü YL; Jiao SC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Aug; 32(4):375-82. PubMed ID: 20868593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.